FOXG1 and glioma: In agreement with these findings, recent work profiling the expression of several forkhead proteins, including FOXG1, as a function of glioma patient survival concluded that forkhead proteins are attractive biomarkers of GBM and warrant further investigation of their roles in gliomagenesis (Robertson et al., 2015).